Archives
-
Epidermal Growth Factor in 3D Glioma Spheroids
2026-09-10
Use recombinant human EGF to build controlled, quantitative 3D glioma spheroid experiments that separate stemness-associated growth from simple proliferation. This workflow combines a validated 96-well format with dose-response design, imaging, and troubleshooting guidance for more reproducible cell-state studies.
-
LDH Cytotoxicity Assay Kit for Nanomaterials
2026-09-09
Learn how the LDH Cytotoxicity Assay Kit can distinguish membrane damage from material-specific assay interference in magnetic nanocomposite studies. This guide translates mechanistic findings on magnetite-coated cellulose nanocrystals into rigorous cell cytotoxicity measurement and experimental design.
-
Nicotinamide Adenine Dinucleotide (NAD+) Guide
2026-09-09
Nicotinamide Adenine Dinucleotide (NAD+) is a redox-active coenzyme, signaling substrate, and NAD+-dependent enzyme substrate. This guide connects NAD+ handling and assay design with metabolic signaling, sirtuin-mediated protein deacetylation, CD38 research, and the updated AMPK–ULK1 energy-stress model.
-
Dexamethasone (DHAP) for Inflammation Research
2026-09-08
Dexamethasone (DHAP) provides a chemically defined benchmark for studying inflammation, immune-cell maturation, stem-cell differentiation, osteosarcoma growth, and neuroinflammation. This practical guide connects the compound with an LPS-stimulated macrophage assay and shows how to improve dosing, controls, readouts, and troubleshooting.
-
Preeclampsia-Associated Senescence in UCMSCs
2026-09-08
A 2025 Placenta study found that umbilical cord mesenchymal stem cells from preeclampsia pregnancies show reduced proliferation, senescence-associated changes, mitochondrial impairment, and cytoskeletal instability despite retained basic stem-cell characteristics. By combining transcriptomics, functional assays, imaging, and a dasatinib–quercetin intervention, the work identifies cellular senescence as a mechanistically relevant and potentially targetable feature of the preeclamptic microenvironment.
-
FXR–KLF11 Protection in Contrast-Induced AKI
2026-09-07
A 2026 study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3-driven inflammation and apoptosis. Its combination of animal, cellular, transcriptomic, promoter-binding, and loss-of-function experiments strengthens the mechanistic case for FXR activation as a prophylactic strategy, while translation beyond experimental models remains unconfirmed.
-
Fenofibrate Workflows for PPARα and YAP Research
2026-09-07
Build reproducible experiments that connect Fenofibrate-driven PPARα activation with lipid metabolism, YAP signaling, liver biology, and cancer-model readouts. This workflow emphasizes formulation, age-aware controls, orthogonal endpoints, and troubleshooting beyond a single viability or organ-weight measurement.
-
Escitalopram Workflows for Serotonergic Research
2026-09-05
Build reproducible Escitalopram assays around transporter selectivity, concentration control, and phenotype-aware analysis. This workflow connects molecular 5-HT reuptake inhibition with translational antidepressant research while keeping anxiolytic activity studies appropriately cautious.
-
Letrozole Workflow for Aromatase Research
2026-09-04
Build reproducible aromatase-inhibition experiments with Letrozole, from DMSO stock preparation to ERα and hormone-response readouts. The workflow distinguishes enzyme potency from downstream biology, helping researchers interpret breast cancer, endocrine-feedback, and exploratory neural-model data more rigorously.
-
One-step TUNEL Cy3 Apoptosis Detection Kit Workflow
2026-09-04
Build a reproducible DNA fragmentation assay for frozen tissue, paraffin sections, adherent cells, suspension cells, and flow cytometry. This workflow also shows how Cy3-TUNEL data can strengthen mechanistic studies such as HLTP1 protection against hepatic ischemia-reperfusion injury.
-
Patient-Derived 3D Spheroids in Prostate Cancer Research
2026-09-03
Linxweiler et al. developed viable, cryopreservable three-dimensional spheroids from radical prostatectomy specimens, addressing the shortage of representative models for organ-confined prostate cancer. The cultures retained important epithelial and prostate cancer markers and enabled comparative drug-response testing, with stronger viability loss after bicalutamide and enzalutamide than after docetaxel or abiraterone.
-
Cyanidin Chloride in Oxidative Stress Assays
2026-09-03
Cyanidin Chloride supports a practical, multiparametric strategy for oxidative stress research, combining reactive oxygen species scavenging assays with cell viability, inflammatory, and barrier-function readouts. This guide translates a psoriasis-model workflow into reproducible assay design while distinguishing direct evidence from recommended starting conditions.
-
Azithromycin and Roxithromycin as Senolytics
2026-09-02
Ozsvari and colleagues used a controlled DNA-damage model in human fibroblasts to identify azithromycin and roxithromycin as selective senolytic candidates. The study is notable for combining viability, real-time impedance, metabolic, autophagic, and mitochondrial analyses while showing that a closely related macrolide, erythromycin, lacked comparable activity.
-
Anti Reverse Cap Analog for High-Expression mRNA
2026-09-02
Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, helps researchers generate orientation-controlled Cap 0 mRNA for stronger, more consistent translation. This guide connects reaction setup, quality control, nanoparticle studies, and troubleshooting to practical mRNA therapeutics research workflows.
-
Nutlin-3a: MDM2 Inhibitor Workflow for p53 Studies
2026-09-01
Nutlin-3a is a practical MDM2 inhibitor for dissecting p53 pathway activation, cell cycle arrest, and apoptosis induction in cancer models. This workflow pairs pharmacologic MDM2 blockade with ferroptosis, lipid-metabolism, and migration assays to help researchers distinguish established effects from testable glioblastoma hypotheses.